Effects of chronic oral administration of isosorbide dinitrate on in vitro contractility of rat arterial smooth muscle

Japanese Journal of Pharmacology

Volumn 71, Issue 2, 1996, Pages 167-173

  Trongvanichnam, Kamolchai ^a   Mitsui Saito, Minori ^a   Ozaki, Hiroshi ^a   Karaki, Hideaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aorta (rat); Chronic treatment; Isosorbide dinitrate; Relaxation

Indexed keywords

8 BROMO CYCLIC GMP; GUANYLATE CYCLASE; ISOSORBIDE DINITRATE; LEMAKALIM; NITROPRUSSIDE SODIUM; NORADRENALIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; ARTERY MUSCLE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION;

EID: 0030018920     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.167     Document Type: Article

References (36)

1. Lopez LM, Lambert CR and Pepine CJ: Pharmacology and mechanisms of action of nitroglycerin and long-acting nitrates. In Nitrate Therapy and Nitrate Tolerance, Edited by Rezakovic DE and Alpert JS, pp 1-48, Karger, Basel (1993)
2. Stipe AA and Fink GB: Prophylactic therapy of angina pectoris with organic nitrates: Relationship of drug efficacy and clinical experimental design. J Clin Pharmacol 13, 244-250 (1973)
3. Franciosa JA, Mikulic E and Cohn JN: Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation 50, 1020-1024 (1974)
4. Cintron GB, Glasser SP, Weston BA, Linares E and Conti CR: Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction. Am J Cardiol 61, 21-25 (1988)
5. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PA and Gruetter CA: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218, 739-749 (1981)
6. Galvas PE and DiSalvo J: Concentration and time-dependent relationships between isosorbide dinitrate-induced relaxation and formation of cyclic GMP in coronary arterial smooth muscle. J Pharmacol Exp Ther 224, 373-378 (1983)
7. Fiscus RR, Rapoport RM and Murad F: Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. J Cyc Nucl Res 9, 415-425 (1983-1984)
8. Nelson M and Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268, C799-C822 (1995)
9. 2+ pump by cyclic nucleotides in cultured vascular smooth muscle. J Biol Chem 263, 8058-8065 (1988)
10. 2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ Res 73, 1128-1137 (1993)
11. Karaki H, Sato K, Ozaki H and Murakami K: Effects of sodium nitroprusside on cytosolic calcium level in vascular smooth muscle. Eur J Pharmacol 156, 259-266 (1988)
12. 2+ influx and contraction in vascular smooth muscle. Jpn J Pharmacol 59, 263-265 (1992)
13. Thadani U, Manyari D, Parker JO and Fung H-L: Tolerance to the circulatory effects of oral isosorbide dinitrate. Circulation 61, 526-535 (1980)
14. Thadani U, Fung H-L, Darke AC and Parker JO: Oral isosorbide dinitrate in angina pectoris. Comparison of duration of action and dose response relationship during acute and sustained therapy. Am J Cardiol 49, 411-417 (1982)
15. Abrams J: Tolerance to organic nitrates. Circulation 74, 1181-1185 (1986)
16. Keith RA, Burkman AM, Sokoloski TD and Fertel RH: Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther 221, 525-531 (1982)
17. Torresi J, Horowitz JD and Dusting GJ: Prevention and reversal of tolerance of nitroglycerin with N-acetylcysteine. J Cardiovasc Pharmacol 7, 777-783 (1985)
18. Uma S and Balcioglu A: Absence of desensitization to the relaxant activity of streptozotocin in isosorbide dinitrate-tolerant rat aorta. J Pharm Pharmacol 45, 148-150 (1993)
19. Packer M: What causes tolerance to nitroglycerin?: The 100-year-old mystery continues. J Am Coll Cardiol 16, 932-935 (1990)
20. Needleman PJ and Johnson EM Jr: Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184, 709-715 (1973)
21. Axelsson KL and Ahlner J: Nitrate tolerance from a biochemical point of view. Drugs 33, 63-68 (1987)
22. Waldman SA, Rapport RM, Ginsberg R and Murad F: Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 35, 3525-3531 (1986)
23. Romanin C and Kukovetz WR: Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation. J Mol Cell Cardiol 21, 41-48 (1989)
24. Ahlner J, Andersson RGG, Axelsson KL, Dahlstrom U and Rydell EL: Development of tolerance to glyceryl trinitrate in an isolated human peripheral vein and its relation to cyclic GMP metabolism. Acta Pharmacol Toxicol 59, 123-128 (1986)
25. 1 in the human isolated saphenous vein. Cardiovasc Drugs Ther 5, 457-462 (1991)
26. Molina CR, Andresen JW, Rapoport RM, Waldman S and Murad F: Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol 10, 371-378 (1987)
27. Berkenboom G, Fontaine J and Degre S: Persistence of the response to SIN1 on isolated coronary arteries rendered tolerant to nitroglycerin in vitro or in vivo. J Cardiovasc Pharmacol 12, 345-349 (1988)
28. Kowaluk EA, Poliszczuk R and Fung HL: Tolerance to relaxation in rat aorta: comparison of an S-nitrothiol with nitroglycerin. Eur J Pharmacol 144, 379-383 (1887)
29. Rapoport RM, Waldman SA, Ginsburg R, Molina CR and Murad F: Effects of glyceryl trinitrate on endothelium-dependent and -independent relaxation and cyclic GMP levels in rat aorta and human coronary artery. J Cardiovasc Pharmacol 10, 82-89 (1987)
30. Tinker JH and Michenfelder JD: Sodium nitroprusside: Pharmacology, toxicology and therapeutics. Anesthesiology 45, 340-354 (1976)
31. Feelisch M and Noack E: Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur J Pharmacol 142, 465-469 (1987)
32. Harrison DG and Bates JN: The nitrovasodilators. New ideas about old drugs. Circulation 87, 1461-1467 (1993)
33. Fung HL, Chung SJ, Bauer JA, Chong S and Kowaluk EA: Biochemical mechanism of organic nitrate action. Am J Cardiol 70, 4B-10B (1992)
34. Bassenge E: Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther 8, 601-610 (1994)
35. Schultz KD, Bohme E, Kreye VAW and Schultz G: Relaxation of hormonally stimulated smooth muscular tissues by the 8- bromo derivative of cyclic GMP. Naunyn Schmiedebergs Arch Pharmacol 306, 1-9 (1979)
36. Trongvanichnam K, Mitsui M, Ozaki H and Karaki H: Effects of chronic oral administration of levcromakalim on in vitro contractile responses of arterial smooth muscle. Eur J Pharmacol (in press)